HCC, a form of liver cancer, represents a substantial global health challenge. Nearly 1
million individuals are diagnosed worldwide, and this number is expected to double within …

Background & Aims Antiviral treatment is known to improve survival in patients with chronic
hepatitis B (CHB)-related hepatocellular carcinoma (HCC). Yet, the treatment uptake in CHB …

Summary Background Hepatitis B virus (HBV) is the leading cause of hepatocellular
carcinoma (HCC) worldwide. It remains incompletely understood in the real world how anti …

Simple Summary Hepatocellular carcinoma (HCC) is the most common form of liver cancer
with a low survival rate worldwide. The number of new cases and deaths from HCC is …

HCC represents the most common type of primary liver cancer, arising within a background
of chronic liver disease and cirrhosis. The most frequent causes include metabolic …

ChronichepatitisBvirus (HBV) infectionisamajorglobalhealthcareproblema… 350 million
people. It can cause various complications including liver failure, hepatic decom‐-pensation …

Background In past years, the diagnosis of hepatocellular carcinoma (HCC) was always
made when the disease was advanced, when patients were symptomatic. However, due to …

A supplement to Liver International is published for the PHC meeting with review articles of
presentations from the meeting by outstanding experts with the most up-to-date information …

Globally, hepatitis B virus (HBV) and/or hepatitis C virus (HCV) infection leads to liver
fibrosis and cirrhosis, which in turn causes resultant hepatocellular carcinoma (HCC) …

Hepatocellular carcinoma (HCC) is the sixth most common type of cancer in the world
associated with high morbidity and mortality. Despite being a significant healthcare burden …